GW Pharmaceuticals Plc (GWPH)

138.59
2.68 1.97
NASDAQ : Health Technology
Prev Close 135.91
Open 136.63
Day Low/High 134.04 / 139.28
52 Wk Low/High 92.65 / 143.37
Volume 462.24K
Avg Volume 393.90K
Exchange NASDAQ
Shares Outstanding 25.30M
Market Cap 3.47B
EPS -6.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

American Electric Power, Fifth Third Bancorp: 'Mad Money' Lightning Round

American Electric Power, Fifth Third Bancorp: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at American Electric Power, Fifth Third Bancorp, Applied Materials, EPR Properties, GW Pharmaceuticals and Longfin.

With Nothing to Buy, Everyone Sells: Cramer's 'Mad Money' Recap (Thur 3/22/18)

With Nothing to Buy, Everyone Sells: Cramer's 'Mad Money' Recap (Thur 3/22/18)

Jim Cramer calls it a tsunami of selling. Not one sector of the stock market got a break in Thursday's tariff-inspired decline.

GW Pharmaceuticals Announces The European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Application (MAA) For Review

GW Pharmaceuticals Announces The European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Application (MAA) For Review

MAA seeking regulatory approval of Epidiolex for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome

Best Biotech Stock Trades and Mergers to Watch in 2018

Best Biotech Stock Trades and Mergers to Watch in 2018

Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Look for this name to jump quickly in popularity in 2018 as investors players search for a convenient way to play the marijuana niche.

California Cannabis Growers Celebrate New Year's Day as Weed Goes Legal

California Cannabis Growers Celebrate New Year's Day as Weed Goes Legal

Consumers in California eagerly await the end to it prohibition on the recreational use of cannabis.

GW Pharmaceuticals Reacquires Full Rights To Develop And Commercialize Sativex® In U.S.

GW Pharmaceuticals Reacquires Full Rights To Develop And Commercialize Sativex® In U.S.

- Previous License Agreement with Otsuka Terminated -

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

Party leaders will have to work toward merging the two versions of tax reform into one final bill.

Hold on for a Wild Ride: Cramer's 'Mad Money' Recap (Friday 12/1/17)

Hold on for a Wild Ride: Cramer's 'Mad Money' Recap (Friday 12/1/17)

From tax cuts to the Flynn fallout, Jim Cramer says investors have to be covered.

Enjoy the Holiday Trading While It Lasts

Enjoy the Holiday Trading While It Lasts

Market momentum goes on a rampage.

TheStreet Quant Rating: D (Sell)